Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
31 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
SPECTRALYS BIOTECH from Charleroi, company number BE0712775992, closed financial year 2025 with a result of € 58,165 after tax. For that financial year SPECTRALYS BIOTECH recorded a gross margin of € 143,689 and equity of € 313,008. Compared with financial year 2024, the result moved from € 29,354 to € 58,165. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 4, 2026.
€ 313,008
▲ 23% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 58,165
▲ 98% vs 2024
Profit after tax over the fiscal year.
€ 146,762
▲ 44% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 50,000 paid out
86 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 71,938
▲ 5% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 14,544
▲ 162% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 23,608
▲ 43% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 107,533 | € 96,564 | € 103,548 | € 143,689 | ▲ 39% |
| Profit after taxes | € 29,811 | € 21,499 | € 29,354 | € 58,165 | ▲ 98% |
| Equity | € 223,529 | € 200,000 | € 253,755 | € 313,008 | ▲ 23% |
| Total debts | € 145,266 | € 76,873 | € 51,466 | € 131,687 | ▲ 156% |
| Cash | € 227,447 | € 126,101 | € 101,733 | € 146,762 | ▲ 44% |
| Retained profit | € 204,929 | € 181,400 | € 181,400 | € 189,565 | ▲ 5% |
| Dividend | € 100,000 | € 45,028 | € 29,354 | € 50,000 | ▲ 70% |
| Balance sheet total | € 368,795 | € 276,873 | € 305,222 | € 444,695 | ▲ 46% |
Key figures of SPECTRALYS BIOTECH, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to SPECTRALYS BIOTECH?
What happened at SPECTRALYS BIOTECH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 58,165 (▲ 98% vs 2024). Source: NBB ↗
- New establishment in Elsene. KBO
- New establishment in Charleroi. KBO
- Allison Derenne became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 29,811 profit in 2022 to € 58,165 profit in 2025.
Paid € 32,512 in corporate taxes since 2022.
Best year ever: 2025, with € 58,165 profit.
Paid out € 224,382 in dividends to the owners in total.
Management
Behind SPECTRALYS BIOTECH is Allison Derenne.
Directors
According to the 2025 annual accounts
Allison Derenne
Director
since 2018
Establishments
Establishment units
Physical locations of this company
Rue Clément Ader 10
6041 Charleroi
Rue Auguste Piccard 48
6041 Charleroi
Active since 8 November 2018
Triomflaan accès 2
1050 Elsene
Active since 1 January 2022
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 31 companies are registered at this address.
All companies at this address →Brussels South Charleroi BioPark Dev
€ 80,186 gross margin · 2025
ImmunXperts
€ 393,338 gross margin · 2024
LYS MEDICAL
€ -309,203 gross margin · 2025
ProtonW.be
€ -7,643 gross margin · 2025
QbD Wallonia
€ 1.5 million gross margin · 2025
+26 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0712.775.992
- VAT number
- BE 0712.775.992
- Registered office
- Rue Clément Ader 10, 6041 Charleroi
- Names & denominations
- SPECTRALYS BIOTECH
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 31 October 2018
- Peppol
- Active · Active since 26 Sept 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Activiteiten van medische beeldvorming en medische laboratoria
Activiteiten van medische laboratoria
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Uitgeven van overige software
Beroepsopleiding
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
+1